Tamar Pirtskhalava
About
In The Last Decade
Tamar Pirtskhalava
27 papers receiving 5.8k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Physiology 3.7k
- Molecular Biology 2.1k
- Epidemiology 1.3k
- Immunology 1.1k
- Aging 703
Countries citing papers authored by Tamar Pirtskhalava
This map shows the geographic impact of Tamar Pirtskhalava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamar Pirtskhalava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamar Pirtskhalava more than expected).
Fields of papers citing papers by Tamar Pirtskhalava
This network shows the impact of papers produced by Tamar Pirtskhalava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamar Pirtskhalava. The network helps show where Tamar Pirtskhalava may publish in the future.
Co-authorship network of co-authors of Tamar Pirtskhalava
This figure shows the co-authorship network connecting the top 25 collaborators of Tamar Pirtskhalava. A scholar is included among the top collaborators of Tamar Pirtskhalava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamar Pirtskhalava. Tamar Pirtskhalava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | A pilot study of senolytics to improve cognition and mobility in older adults at risk for Alzheimer’s disease breakdown → | 16 |
| 2 | 15 | |
| 3 | 9 | |
| 4 | 8 | |
| 5 | 1 | |
| 6 | Targeting cellular senescence prevents age-related bone loss in mice breakdown → | 819 |
| 7 | New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463 breakdown → | 531 |
| 8 | 287 | |
| 9 | Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice breakdown → | 564 |
| 10 | JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age breakdown → | 631 |
| 11 | 68 | |
| 12 | 19 | |
| 13 | 80 | |
| 14 | 59 | |
| 15 | 63 | |
| 16 | 276 | |
| 17 | 189 | |
| 18 | 46 | |
| 19 | 274 | |
| 20 | 214 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.